Axonis Logo
  • About Us
    • Our Mission
    • Key Personnel
      • Corey S. Goodman, Ph.D.
      • Joanna Stanicka, Ph.D.
      • Bob Yant
      • Richard A. Sipos
      • Patrick J. Carew, MBA, FACHE, CFRE
      • Oswald Steward, Ph.D.
      • Lisa McKerracher, Ph.D.
      • Mark R. E. Pinney, M.B.A., M.Sc., C.F.A.
  • News
  • Our Science
    • KCC2 Upmodulation
    • PTEN Inhibition
    • Publications
  • Patient Information
  • Contact Us

Using breakthrough research to end paralysis Read More > "One of the most dramatic results Ben Barres M.D., Ph.D. Stanford University Read More > in the history of this field" Today there is a real possibility to develop therapies that restore connections Read More > in the spinal cord AXONIS Therapeutics is using breakthrough research to end paralysis Read More >
SHARE:
  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • About Us
    • Our Mission
    • Key Personnel
      • Corey S. Goodman, Ph.D.
      • Joanna Stanicka, Ph.D.
      • Bob Yant
      • Richard A. Sipos
      • Patrick J. Carew, MBA, FACHE, CFRE
      • Oswald Steward, Ph.D.
      • Lisa McKerracher, Ph.D.
      • Mark R. E. Pinney, M.B.A., M.Sc., C.F.A.
  • News
  • Our Science
    • KCC2 Upmodulation
    • PTEN Inhibition
    • Publications
  • Patient Information
  • Contact Us

© 2020 Axonis. All rights reserved. | Website: David Kerr Design

Scroll Up
Axonis Home
  • About Us
    ▼
    • Our Mission
    • Key Personnel
      ▼
      • Corey S. Goodman, Ph.D.
      • Joanna Stanicka, Ph.D.
      • Bob Yant
      • Richard A. Sipos
      • Patrick J. Carew, MBA, FACHE, CFRE
      • Oswald Steward, Ph.D.
      • Lisa McKerracher, Ph.D.
      • Mark R. E. Pinney, M.B.A., M.Sc., C.F.A.
  • News
  • Our Science
    ▼
    • KCC2 Upmodulation
    • PTEN Inhibition
    • Publications
  • Patient Information
  • Contact Us